![Alnylam](https://pharmaphorum.com/wp-content/uploads/2016/07/Alnylam-scaled.jpg)
UK patients get early access to Alnylam's ultra-rare disease...
The UK's regulator has granted early access to Alnylam's ultra-rare disease drug lumasiran, allowing patients with primary hyperoxaluria type 1 to gain access ahead of a regulatory decision